How will the NHS’s evolution towards integrated care unfold?
Triducive’s Tim Warren explores how pharma can succeed within the newly emerging integrated commissioning landscape.
As Prime Minister Theresa May promises £20 billion more funding...
Segmentation: The hidden source of commercial success in a multi-channel world?
Multichannel has been a hot topic in pharma for many years, specifically the quest for the right integrated customer engagement model.
The focus has been...
Brands by numbers: Launch excellence in an increasingly specialised world
As the focus turns to specialist therapy areas and competition increases, achieving a successful launch is becoming even more challenging.
Implementing the national brand strategy at local level
National brand messages for general biological medicines must be tailored to patients and clinicians at a local level, and dovetailed with the needs, priorities...
How to harness the power of data for brand planning
Brand planning: Getting general biological brands established in a fast changing and cash-strapped NHS requires deep customer insight and a strong evidence-based strategy that will...
What does multichannel marketing mean in reality?
How do we develop a multichannel go-to-market plan and move from marketing speak to effective marketing deployment?
Multichannel marketing in the pharmaceutical commercial mix is...
Who’s at the heart of your brand launch?
Launching a new pharma product in the UK can be a brutal process. It’s expensive, time-consuming and highly competitive. How do you maximise the...
Does great brand planning make the difference?
As the hot summer days begin to fade behind us, thoughts start to turn towards next year. Teams are ramping up their planning activities...
Surgeon takes prostate cancer screening to the community
Surgeon Jyoti Shah won’t let men die of embarrassment. Instead of waiting for patients to come to her, she goes out and gets them.
What’s driving a resurgence in primary care pharma representatives?
After flirting with remote detailing, pharma is returning to feet-on-the-ground sales to meet the complex challenges of transforming markets and changing decision makers.
Read this...
Latest articles
Maxwellia expand their team with two new appointments
Maxwellia has expanded their team of switch experts with two new appointments following their relocation to the Alderley Park Accelerator.
BMS & Boston Medical Center announce research collaboration
BMS & Boston Medical Center enter research collaboration to investigate markers of immuno-oncology response and resistance Bristol-Myers Squibb Company...
EC approves KEYTRUDA® as adjuvant therapy
MSD (Merck in the U.S. and Canada) has announced that the European Commission has approved its anti-PD-1 therapy, KEYTRUDA (pembrolizumab), for the adjuvant treatment...